LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin...

Source: Cancer Cell International - March 21, 2019 Category: Cancer & Oncology Authors: Nagaja Capitani, Giulia Lori, Paolo Paoli, Laura Patrussi, Arianna Troilo, Cosima T. Baldari, Giovanni Raugei and Mario Milco D ’Elios Tags: Primary research Source Type: research